Geary v. Parexel International Corporation

District Court, N.D. California·Decided March 18, 2022·No. 5:19-cv-07322·Unknown

Opinion

WILLIAM JOHN GEARY, Case No. 5:19-cv-07322-EJD

Plaintiff, ORDER GRANTING MOTION TO DISMISS WITH LEAVE TO AMEND v.

PAREXEL INTERNATIONAL Re: Dkt. No. 122 CORPORATION, et al., Defendants.

Plaintiff William John Geary III, proceeding pro se, brings this action against Defendant Parexel International Corporation (“Parexel”) and its individual officers, executives, and directors (collectively, “the Individual Defendants”), asserting the following claims: (1) retaliation in violation of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley”), 18 U.S.C. § 1514A against all Defendants; (2) retaliation in violation of the Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank”), 15 U.S.C. § 78u-6 against all Defendants; (3) retaliation through wrongful termination in violation of California Labor Code § 1102.5 against Parexel1; and (4) wrongful termination in violation of public policy against all Defendants. Compl., Dkt. No. 1. Defendants now move to dismiss the complaint under Federal Rules of Civil Procedure 12(b)(1) and (6). Defs.’ Not. of Mot. and Mot. to Dismiss Plf.’s Compl. Pursuant to F.R.C.P. 12(b)(1) and

1 In the text of the Complaint, Geary lists both the third and fourth claim as “wrongful termination in violation of public policy,” but on the caption of the Complaint, he describes his third claim as retaliation under California Labor Code § 1102.5 and the fourth claim as wrongful termination in violation of public policy. F.R.C.P. 12(b)(6) (“Mot.”), Dkt. No. 122. The Court finds the motion appropriate for decision without oral argument pursuant to Civil Local Rule 7-1(b). Having considered the parties’ written submissions, the Court GRANTS the motion with leave to amend. Parexel is a clinical research service company headquartered in Waltham, Massachusetts, with approximately 18,600 employees across 52 countries. Compl. ¶ 13. The Individual Defendants consist of: Parexel co-founder, Chairman of the Board of Directors, and Chief Executive Officer Josef H. von Rickenbach; President, Chief Operating Officer, and Director Mark A. Goldberg, M.D.; Senior Vice President, Clinical Research Services and Director Roland Andersson, Ph.D.; Senior Vice President, Chief Financial Officer, and Director Ingo Bank; Senior Vice President, General Counsel, Secretary, and Director Douglas A. Batt; Parexel Informatics President and Parexel Director Xavier Flinois; Senior Vice President, Clinical Research Services and Director Gadi Saarony; Senior Vice President, Chief Administrative Officer, and Director Ulf Schneider, Ph.D.; Senior Vice President, Clinical Research Services and Director Thomas Senderovitz, M.D.; Director A. Dana Callow, Jr.; Director Patrick J. Fortune, Ph.D.; Director Maykin Ho, Ph.D.; Director Eduard E. Holdener, M.D.; Director Christopher J. Lindop; Director Richard L. Love; and Director Ellen M. Zane.2 Id. ¶¶ 14-15. Geary is a resident of San Jose, California. Id. ¶ 13. In February 2014, Parexel hired Geary to work from home as a Sr. Project Leader. Id. ¶ 8. In that role, Geary was responsible for calculating and reporting accrual of recognized revenue and attesting to accuracy of expenses prior to submitting them to clients for reimbursement. Id. ¶ 11. In August 2014, Geary was assigned to be the Sr. Project Leader for Parexel client Pharmacyclics, Inc. (“PCYC”). Id. ¶¶ 9, 19. He says he was selected to “rescue a failing project” (the “PCYC Project”). Id. ¶ 19. Upon assuming leadership of the PCYC Project, Geary “reported

Free access — add to your briefcase to read the full text and ask questions with AI

Geary v. Parexel International Corporation, (N.D. Cal. 2022).

Geary v. Parexel International Corporation (Geary v. Parexel International Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Mendiondo v. Centinela Hospital Medical Center
521 F.3d 1097 (Ninth Circuit, 2008)
Mathieu v. Norrell Corp.
10 Cal. Rptr. 3d 52 (California Court of Appeal, 2004)
Lawson v. FMR LLC
134 S. Ct. 1158 (Supreme Court, 2014)
Prue v. Brady Company/San Diego, Inc. CA4/1
242 Cal. App. 4th 1367 (California Court of Appeal, 2015)
Artis v. District of Columbia
583 U.S. 71 (Supreme Court, 2018)
Karim Khoja v. Orexigen Therapeutics, Inc.
899 F.3d 988 (Ninth Circuit, 2018)
Romano v. Rockwell International, Inc.
926 P.2d 1114 (California Supreme Court, 1996)
Wadler v. Bio-Rad Laboratories, Inc.
141 F. Supp. 3d 1005 (N.D. California, 2015)
Safe Air for Everyone v. Meyer
373 F.3d 1035 (Ninth Circuit, 2004)